BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Phase 1 Data on Isis-ANGPTL3Rx 3/23/2015 6:35:58 AM
Interleukin Genetics Inc. (ILGN) Expands Its Collaboration With Isis Pharmaceuticals, Inc. (ISIS) For Genetic Testing Services 3/9/2015 10:24:22 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $9 Million For Advancing ISIS-SMN Rx In Infants With Spinal Muscular Atrophy 3/6/2015 6:46:48 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $15 Million From GlaxoSmithKline (GSK) for Advancing ISIS-TTR Rx 3/2/2015 7:04:21 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results And Highlights For 2014 2/27/2015 10:34:43 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx Produces Significant Reductions In Prekallikrein Levels 2/24/2015 9:09:07 AM
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' 2014 Financial Results And Highlights Conference Call 2/20/2015 10:37:22 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $5 Million Milestone Payment From Biogen Idec (BIIB) 2/10/2015 7:37:47 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $10 Million Milestone Payment From Biogen Idec For Advancing New Drug Into Development To Treat A Neurodegenerative Disease 2/5/2015 7:22:32 AM
Isis Pharmaceuticals, Inc. (ISIS) To Present At Upcoming Investor Conferences 2/4/2015 11:08:12 AM
12345678910...